Bristol-myers Squibb Compnay

Samayamunthula Venkata Satya Arun Kumar Gupta

John F Kadow

Nicholas A Meanwell

Piyasena Hewawasam

Makonen Belema

Omar D Lopez

Alan Xiangdong Wang

Yong Tu

Ningning Xu

Kap-Sun Yeung

Rajesh Onkardas Bora

Prakash Anjanappa

Mark George Saulnier

Gan Wang

Van N Nguyen

David Bertil Frennesson

Bingwei Vera Yang

Hasibur Rahaman

Kumaravel Selvakumar

Gregory D Brown

Julie A Lemm

Ying-Kai Wang

Robert A Fridell

Pothukanuri Srinivasu

Donald R O'Boyle, Ii

Jin-Hua Sun

Ponugupati Suresh Kumar

Chunfu Wang

Indasi Gopi Kumar

Suresh Kumar Ponugupati

Indasi J Gopi Kumar

Roshan Yadavrao Nimje

Suresh Kumar Punugupati

Donald R O'BOYLE Ii

The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. 

Benzofuran derivatives for the treatment of hepatitis C

The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.

Hepatitis C virus inhibitors

The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. 

Compounds for the treatment of hepatitis C

Growing community of inventors

Bengaluru, India

Samayamunthula Venkata Satya Arun Kumar Gupta